- Home
- » Tags
- » Norbinaltorphimine
Top View
- Pharmacological Characterization of Novel Opioid Receptor Ligands Aimed at Reducing the Development of Tolerance
- Salvinorin a As a Potential Medication for Stroke John Grothusen, Phd and Renyu Liu, MD, Phd*
- Distinct Components of Morphine Effects on Cardiac Myocytes Are Mediated by the J and D Opioid Receptors
- 14-O-Methylmorphine a Novel Selective Mu-Opioid Receptor
- Acute and Post-Acute Behavioral and Psychological Effects of Salvinorin a in Humans
- Discovery of Novel Opioid Medications
- Prior Activation of Kappa Opioid Receptors by U50,488 Mimics Repeated Forced Swim Stress to Potentiate Cocaine Place Preference Conditioning
- Nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior" (2016)
- Motivational Effects of Cannabinoids Are Mediated by Μ-Opioid and Κ
- Salvinorin a Produces Cerebrovasodilation Through Activation of Nitric Oxide Synthase, Receptor, and Adenosine Triphosphate–Sensitive Potassium Channel
- Oxycodone- Induced Tolerance to Respiratory Depression: Reversal by Ethanol, Pregabalin and Protein Kinase C Inhibition
- Medical Cannabis As a Substitute for Opioids Are We Building an Ark Or a Tower?
- Sex Differences in Kappa Opioid Pharmacology
- GSC Advanced Research and Reviews Nsaids and Opioids
- K-Opioids Decrease Excitatory Transmission in the Dentate Gyrus of the Guinea Pig Hippocampus
- Drugs of Abuse: Chemistry, Pharmacology, Immunology, and AIDS, 96
- Neuropeptides in the Bed Nucleus Stria Terminalis: Implications in Chronic Stress
- JPET #183343 Acute Oxycodone Induces the Pro-Emetic Pica
- P-Methoxy-Butyrylfentanyl
- (12) United States Patent (10) Patent No.: US 8,617,577 B2 Crain Et Al
- The Use of Buprenorphine/Naltrexone Combination Treatment in Attenuating Relapse to Morphine/Methamphetamine Polydrug-Dependence in Mice
- A Single Compound Alternative to a Buprenorphine/Naltrexone Combination Irna Elina Ridzwan a Thesis Submitted for the Degree Of
- NMDAR-Independent, Camp-Dependent Antidepressant Actions of Ketamine
- World Journal of Advanced Research and Reviews
- Dr. Youssef Sari, Committee Chair 19 20 21 ______22 Dr
- (12) INNOVATION PATENT (11) Application No. AU 2018100925 A4 (19) AUSTRALIAN PATENT OFFICE
- Monday, December 4, 2006 Panel Session Co-Morbid Pain
- Long-Term Reduction of Kappa Opioid Receptor Function by The
- Fentanyl Depression of Respiration: Comparison with Heroin and Morphine
- Psychotropic Drugs for the Management of Chronic Pain and Itch
- Analgesic Drugs Combinations in the Treatment of Different Types of Pain
- Dosage Form Containing Oxycodone and Naloxone Darreichungsform Enthaltend Oxycodon Und Naloxon Forme Posologique Contenant De L’Oxycodone Et De La Naloxone
- NDSP Catalog 23Rd Edition
- Medicinal Properties of Cannabinoids, Terpenes, And
- Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through
- Neuropharmacological Mechanisms Underlying Incentive Salience and Stress
- Buprenorphine Antinociception Is Abolished, but Naloxone-Sensitive Reward Is Retained, in Μ-Opioid Receptor Knockout Mice
- The Endocannabinoid System, Cannabinoids, and Pain
- Effects of Stress Mechanisms on Pain Processing
- Kappa Opioid Receptor Antagonism and Chronic Antidepressant
- Et Hers of Opioid Ligands Derived from Oxymorphone, Naltrexone, Etorphine, Diprenorphine, Norbinaltorphimine, and Naltrindole
- Antidepressant-Like Effects of Buprenorphine Are Mediated by Kappa Opioid Receptors
- Pharmacology of Opioid Inhibition to Noxious Uterine Cervical Distension Andreas Sandner-Kiesling, M.D.,* James C
- View Full Page
- Pharmacokinetic Neuroimaging to Study the Dose-Related
- Antinociceptive Profile of Salvinorin A, a Structurally Unique Kappa Opioid Receptor Agonist
- Directing Bitopic Or Bivalent Molecules to Dopamine D3 Receptors for the Treatment of Substance Use Disorders
- Monograph Series
- The Effects of Perinatal Oxycodone Exposure on the Stress Axis and Neurobehavior
- Salvinorin A: Fragment Synthesis and Modeling Studies
- IIIHIH III USOO5457208A United States Patent (19) 11 Patent Number: 5,457,208 Portoghese Et Al
- TITLE PAGE Withdrawal-Induced Escalated Oxycodone Self
- Patterns of Medicinal Cannabis Use, Strain Analysis, and Substitution
- Opiate States of Memory: Receptor Mechanisms
- Differences Between and Combinations of Opioids Re-Visited Maree T
- Pharmacokinetic Evaluation of a Novel Compound, Sn79, a Putative Sigma-2 Receptor Antagonist, by Intravenous and Oral Administration in Rats